These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
828 related items for PubMed ID: 25687746
1. Clinical course and prognostic relevance of antitachycardia pacing-terminated ventricular tachyarrhythmias in implantable cardioverter-defibrillator patients. Kleemann T, Strauss M, Kouraki K, Zahn R. Europace; 2015 Jul; 17(7):1068-75. PubMed ID: 25687746 [Abstract] [Full Text] [Related]
2. Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia. Roses-Noguer F, Jarman JW, Clague JR, Till J. Heart Rhythm; 2014 Jan; 11(1):58-66. PubMed ID: 24120999 [Abstract] [Full Text] [Related]
3. Implantable cardioverter-defibrillator programming and electrical storm: Results of the OBSERVational registry On long-term outcome of ICD patients (OBSERVO-ICD). Guerra F, Palmisano P, Dell'Era G, Ziacchi M, Ammendola E, Bonelli P, Patani F, Cupido C, Devecchi C, Accogli M, Occhetta E, Santangelo L, Biffi M, Boriani G, Capucci A, Italian Association of Arrhythmology and Cardiac Pacing (AIAC). Heart Rhythm; 2016 Oct; 13(10):1987-92. PubMed ID: 27291511 [Abstract] [Full Text] [Related]
4. The association between ICD interventions and mortality is independent of their modality: clinical implications. Bencardino G, Di Monaco A, Rio T, Frontera A, Santangeli P, Leo M, Pelargonio G, Perna F, Narducci ML, Gabrielli F, Lanza GA, Bellocci F, Rebuzzi A, Crea F. J Cardiovasc Electrophysiol; 2014 Dec; 25(12):1363-7. PubMed ID: 25066621 [Abstract] [Full Text] [Related]
5. Ventricular tachycardia or ventricular fibrillation occurs less often in patients with left bundle branch block and combined resynchronization and defibrillators than in patients with narrow QRS and conventional defibrillators. Blaschke F, Knaus T, Celebi O, Krebs A, Nitardy A, Habedank D, Dietz R, Stockburger M. Europace; 2012 Feb; 14(2):224-9. PubMed ID: 21946820 [Abstract] [Full Text] [Related]
6. Differences in effects of electrical therapy type for ventricular arrhythmias on mortality in implantable cardioverter-defibrillator patients. Sweeney MO, Sherfesee L, DeGroot PJ, Wathen MS, Wilkoff BL. Heart Rhythm; 2010 Mar; 7(3):353-60. PubMed ID: 20185109 [Abstract] [Full Text] [Related]
7. Antitachycardia pacing for spontaneous rapid ventricular tachycardia in patients with prophylactic cardioverter-defibrillator therapy. Grimm W, Plachta E, Maisch B. Pacing Clin Electrophysiol; 2006 Jul; 29(7):759-64. PubMed ID: 16884513 [Abstract] [Full Text] [Related]
8. Arrhythmia rate distribution and tachyarrhythmia therapy in an ICD population: results from the INTRINSIC RV trial. Sullivan RM, Russo AM, Berg KC, Stolen KQ, Seth M, Perschbacher D, Day JD, Olshansky B. Heart Rhythm; 2012 Mar; 9(3):351-8. PubMed ID: 22016074 [Abstract] [Full Text] [Related]
9. Predictors of all-cause mortality for patients with chronic Chagas' heart disease receiving implantable cardioverter defibrillator therapy. Cardinalli-Neto A, Bestetti RB, Cordeiro JA, Rodrigues VC. J Cardiovasc Electrophysiol; 2007 Dec; 18(12):1236-40. PubMed ID: 17900257 [Abstract] [Full Text] [Related]
10. Obesity as a risk factor for sustained ventricular tachyarrhythmias in MADIT II patients. Pietrasik G, Goldenberg I, McNitt S, Moss AJ, Zareba W. J Cardiovasc Electrophysiol; 2007 Feb; 18(2):181-4. PubMed ID: 17338766 [Abstract] [Full Text] [Related]
11. Comparison of age (<75 Years versus ≥75 Years) to risk of ventricular tachyarrhythmias and implantable cardioverter defibrillator shocks (from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy). Aktas MK, Goldenberg I, Moss AJ, Huang DT, Kutyifa V, Wang PJ, Brenyo A, McNitt S, Zareba W, Barsheshet A. Am J Cardiol; 2014 Dec 15; 114(12):1855-60. PubMed ID: 25438913 [Abstract] [Full Text] [Related]
15. Right ventricular pacing is associated with impaired overall survival, but not with an increased incidence of ventricular tachyarrhythmias in routine cardioverter/defibrillator recipients with reservedly programmed pacing. Stockburger M, Celebi O, Krebs A, Knaus T, Nitardy A, Habedank D, Dietz R. Europace; 2009 Jul 15; 11(7):924-30. PubMed ID: 19447808 [Abstract] [Full Text] [Related]
16. [Long-term outcome after cardioverter-defibrillator implantation in patients with Brugada syndrome]. Binbin Y, Jingping L, Bing Y, Minglong C, Jiangang Z, Kejiang C, Qijun S. Zhonghua Xin Xue Guan Bing Za Zhi; 2015 Aug 15; 43(8):690-4. PubMed ID: 26955725 [Abstract] [Full Text] [Related]
19. Long-term follow-up of patients with cardiac sarcoidosis and implantable cardioverter-defibrillators. Betensky BP, Tschabrunn CM, Zado ES, Goldberg LR, Marchlinski FE, Garcia FC, Cooper JM. Heart Rhythm; 2012 Jun 15; 9(6):884-91. PubMed ID: 22338670 [Abstract] [Full Text] [Related]
20. Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability. Lelakowski J, Piekarz J, Rydlewska A, Majewski J, Senderek T, Ząbek A, Małecka B. Kardiol Pol; 2012 Jun 15; 70(11):1099-110. PubMed ID: 23180517 [Abstract] [Full Text] [Related] Page: [Next] [New Search]